UL38 mediates this rigid activation of fatty acid biosynthesis via inhibition of the TSC2 tumor suppressor, the inactivation of which also causes rigid activation of fatty acid biosynthesis and sensitivity to glucose limitation (Fig. 9). Here, TSC2 is linked to neoplasm.